Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch
Go back to Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 312.37 +2.01 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $310.36 | 52 Week High | $139.79 | |||
| Open | $310.52 | 52 Week Low | $82.07 | |||
| Day High | $317.23 | P/E | 726.44 | |||
| Day Low | $306.95 | EPS | $0.43 | |||
| Volume | 500,757 | |||||

